Results 211 to 220 of about 480,371 (358)

Thyroid Cancer: Pathogenesis, Clinicopathology, Diagnosis, and Management. [PDF]

MedComm (2020)
Li YD, Ye QY, Chen YX, Hu XR.
europepmc   +1 more source

Advancements in Targeted Radiopharmaceuticals: Innovations in Diagnosis and Therapy for Enhanced Cancer Management

ChemBioChem, EarlyView.
Radiopharmaceuticals enable precise cancer diagnosis and targeted therapy by combining radioactive isotopes with carrier molecules. This review summarizes advances from 2014 to 2025, emphasizing probe design, click chemistry, novel targets, and nanodelivery systems.
Mohd Sayeed Shaikh, Rupesh R. Kurhade, Abrar A. M. Siddiqui, Shaikh Shahbaz A. Majeed, Thomas J. Webster, Mohammad Intakhab Alam, Abdul Wasy Zia, Md. Faiyazuddin   +7 more
wiley   +1 more source

Tertiary lymphoid structures in thyroid cancer. [PDF]

Arch Endocrinol Metab
Nakadaira KS, Saito KC, Fuziwara CS, Magalhães PKR, Ramalho LNZ, Ricarte-Filho JC, Maciel LMZ, Kimura ET.   +7 more
europepmc   +1 more source

Invited Editorial About: Tailored Surgery for Medullary Thyroid Cancer (MTC) Based on Pretherapeutic Basal Calcitonin and Intraoperative Diagnosis of Desmoplastic Stroma Reaction: A Proposal for a New Surgical Concept [PDF]

Gabriela L. Aitken, Olivia M. DeLozier, Paxton V. Dickson   +2 more
openalex   +1 more source

An Evaluation of the Drug Interaction Potential of Encorafenib in Combination With Binimetinib Using the Inje Cocktail in Patients With Cancer

Clinical Pharmacology &Therapeutics, EarlyView.
A clinical drug–drug interaction (DDI) study was designed to evaluate the effect of single and multiple oral doses of encorafenib on the single oral dose pharmacokinetics (PK) of the cytochrome P450 (CYP) enzyme probe substrates, losartan (CYP2C9), midazolam (CYP3A4), caffeine (CYP1A2), omeprazole (CYP2C19), and dextromethorphan (CYP2D6) administered ...
Joseph Piscitelli, Micaela B. Reddy, Lance Wollenberg, Laurence Del Frari, Jason Gong, Kyle Matschke, Jason H. Williams   +6 more
wiley   +1 more source

Immunomodulatory effects of lenvatinib in patients with advanced thyroid cancer. [PDF]

Cancer Immunol Immunother
Changoer P, Peng C, van Houten P, van Emst L, Walraven JEW, Ottevanger PB, Jaeger M, Netea-Maier RT.   +7 more
europepmc   +1 more source

Differences in health state valuation for small, low-risk thyroid cancer between general population and cancer survivors: a cross-sectional analysis [PDF]

Kendyl Carlisle, Rebecca Kowalski, Aprill N. Park, Salome Ricci, Kai Sun, Carrie Cunningham, Julia F. Slejko, C. Daniel Mullins, Yinin Hu   +8 more
openalex   +1 more source

Extent and Incidence of Pseudo‐Worsening of Kidney Function Due to Oral Antitumor Therapeutics in the AMBORA Cohort: An Analysis of Real‐World Data

Clinical Pharmacology &Therapeutics, EarlyView.
A considerable number of oral antitumor therapeutics (OAT) has the potential for causing pseudo‐worsening of kidney function (PW) due to inhibition of renal creatinine secretion, i.e., kidney function is unaffected, while creatinine‐based calculation of glomerular filtration rate (eGFR) erroneously indicates an impaired kidney function.
Michael I. Sponfeldner, Pauline Dürr, Phyllis Lensker, Katja Gessner, Lisa Cuba, Rainer Fietkau, Markus F. Neurath, Bernd Wullich, Marianne Pavel, Carola Berking, Matthias W. Beckmann, Andreas Mackensen, Frank Dörje, Martin F. Fromm   +13 more
wiley   +1 more source

Prognosis of differentiated thyroid cancer in patients with Graves' disease: a meta-analysis. [PDF]

Thyroid Res
Zhang D, Zhang G, Li Y, Liu H, Shan Z, Teng W.   +5 more
europepmc   +1 more source

Clinical Safety of Extended Interval Dosing of Nivolumab in Patients with Melanoma

Clinical Pharmacology &Therapeutics, EarlyView.
Extended interval dosing regimens of immune checkpoint inhibitors have been implemented widely. However, their approval was mainly based on pharmacokinetic modeling and simulations. Consequently, comparative safety data of extended interval dosing regimens in a real‐world setting are limited.
Ruben Malmberg, Maaike M. Hofman, Fatima Ashad, Alaa Daloul, Stefani Oosterveld, Edwin A. Basak, Esther Oomen‐de Hoop, Astrid A. M. van der Veldt, Arjen Joosse, Roelof W. F. van Leeuwen, Ron H. J. Mathijssen   +10 more
wiley   +1 more source